The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

January 1, 2023

Study Completion Date

April 1, 2023

Conditions
Chronic Heart FailureNon-ischemic CardiomyopathyNon-ischemic Dilated Cardiomyopathy
Interventions
BIOLOGICAL

Intracoronary administration of umbilical cord-derived MSCs

A suspension of 1×10⁷ umbilical cord-derived mesenchymal stromal cells in 20 ml of heparinized saline was administered by intracoronary infusion into the left coronary artery via a standard 6 Fr catheter over 10 minutes (2 ml/min). The infusion was performed without balloon occlusion or interruption of coronary blood flow.

Trial Locations (1)

080000

The Research-Clinical Center for Cardiac Surgery and Transplantology LLP, Taraz

All Listed Sponsors
collaborator

"State-Financed Health Facility Samara Regional Medical Center Dinasty"

OTHER

lead

The Research-Clinical Center for Cardiac Surgery and Transplantology LLP

OTHER

NCT04325594 - The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure | Biotech Hunter | Biotech Hunter